Literature DB >> 8259429

Adrenocorticotropic hormone--secreting islet cell tumors: are they always malignant?

J L Doppman1, L K Nieman, G B Cutler, G P Chrousos, D L Fraker, J A Norton, R T Jensen.   

Abstract

PURPOSE: To evaluate the frequency with which benign occult islet cell tumors cause ectopic adrenocorticotropic hormone (ACTH) syndrome.
MATERIALS AND METHODS: Ten patients with Cushing syndrome due to the production of ACTH by a pancreatic islet cell tumor were studied. In addition, 53 cases of ACTH-secreting islet cell tumors in the English-language literature were reviewed.
RESULTS: All 10 of the authors' patients had malignant islet cell tumors. Liver metastases were present in all 10 patients at presentation. Five patients are dead, four patients are alive with liver metastases, and one patient is alive without gross evidence of residual tumor after distal pancreatectomy and right hepatectomy. Eight of the 10 islet cell carcinomas produced gastrin in addition to ACTH. In the 53 reported cases of ectopic ACTH production, there was only one benign adenoma with a prolonged follow-up.
CONCLUSION: When ectopic ACTH production is caused by an islet cell tumor, the tumor is large and malignant and has usually metastasized to the liver by the time Cushing syndrome is diagnosed. No occult ACTH-producing islet cell tumor was encountered in the authors' experience or in a review of the literature.

Entities:  

Mesh:

Year:  1994        PMID: 8259429     DOI: 10.1148/radiology.190.1.8259429

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  9 in total

1.  Ectopic Adrenocorticotropic Hormone Syndrome Due to a Pancreatic Neuroendocrine Tumor.

Authors:  Meghana Bansal; Abhishek Agarwal; R Govindarajan
Journal:  J Gastrointest Cancer       Date:  2012-09

Review 2.  Imaging of neuroendocrine tumors of the pancreas.

Authors:  J L Fidler; C D Johnson
Journal:  Int J Gastrointest Cancer       Date:  2001

3.  Spindle cell pancreatic endocrine tumor associated with Cushing's syndrome.

Authors:  Runjan Chetty; Stefano Serra
Journal:  Endocr Pathol       Date:  2005       Impact factor: 3.943

4.  Metastatic pancreatic neuroendocrine carcinoma causing Cushing's syndrome. ACTH secretion by metastases 3 years after resection of nonfunctioning primary cancer.

Authors:  L Zhu; D R Domenico; J M Howard
Journal:  Int J Pancreatol       Date:  1996-06

Review 5.  Pharmacotherapy of Zollinger-Ellison syndrome.

Authors:  Tetsuhide Ito; Hisato Igarashi; Hirotsugu Uehara; Robert T Jensen
Journal:  Expert Opin Pharmacother       Date:  2013-01-30       Impact factor: 3.889

6.  ACTH-secreting pancreatic neuroendocrine carcinoma with ovarian and pelvic metastases causing Cushing's syndrome: a case report.

Authors:  Wen-Qing Yao; Xia Wu; Gan-Di Li; Wei-Lu Wu; Wei-Ya Wang
Journal:  Int J Clin Exp Pathol       Date:  2015-11-01

7.  Perspectives on the current pharmacotherapeutic strategies for management of functional neuroendocrine tumor syndromes.

Authors:  Tetsuhide Ito; Robert T Jensen
Journal:  Expert Opin Pharmacother       Date:  2020-11-11       Impact factor: 3.889

8.  Ectopic Cushing' syndrome caused by a neuroendocrine carcinoma of the mesentery.

Authors:  Mathias Fasshauer; Thomas Lincke; Helmut Witzigmann; Regine Kluge; Andrea Tannapfel; Michael Moche; Michael Buchfelder; Stephan Petersenn; Juergen Kratzsch; Ralf Paschke; Christian A Koch
Journal:  BMC Cancer       Date:  2006-04-27       Impact factor: 4.430

9.  ACTH-producing neuroendocrine tumor of the pancreas: a case report and literature review.

Authors:  Justin Byun; Sung Hyun Kim; Hyang Sook Jeong; Yumie Rhee; Woo Jung Lee; Chang Moo Kang
Journal:  Ann Hepatobiliary Pancreat Surg       Date:  2017-02-28
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.